🇺🇸 Amodiaquine Sulfadoxine-Pyrimethamin administration in United States

Amodiaquine Sulfadoxine-Pyrimethamin administration (Amodiaquine Sulfadoxine-Pyrimethamin administration) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Amodiaquine Sulfadoxine-Pyrimethamin administration in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Amodiaquine Sulfadoxine-Pyrimethamin administration approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Amodiaquine Sulfadoxine-Pyrimethamin administration in United States?

Institut de Recherche en Sciences de la Sante, Burkina Faso is the originator. The local marketing authorisation holder may differ — check the official source linked above.